Leriglitazone, CAS [[146062-44-4]]

Produktübersicht

• Artikelname: Leriglitazone, CAS [[146062-44-4]]
• Artikelnummer: MCE-HY-117727
• Hersteller Artikelnummer: HY-117727
• Alternativnummer: MCE-HY-117727-50MG,MCE-HY-117727-5MG,MCE-HY-117727-100MG,MCE-HY-117727-10MG,MCE-HY-117727-25MG,MCE-HY-117727-10MMX1ML
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: MIN-102, Hydroxypioglitazone

Produktbeschreibung

Leriglitazone (MIN-102, Hydroxypioglitazone) is an orally active and a BBB-penetrable PPARgamma agonist with an EC50 of 9 µM. Leriglitazone, as a regulator of mitochondrial function, has neuroprotective, anti-inflammatory and antioxidant effects. Leriglitazone can be used in the study of neuroinflammatory and neurodegenerative diseases[1][2][3][4].

Produkteigenschaften

• Molekulargewicht: 372.44
• Reinheit: 99.23
• CAS Nummer: [146062-44-4]
• Formel: C19H20N2O4S
• Target-Kategorie: PPAR

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound